Growth Metrics

Boston Scientific (BSX) Short term Debt (2016 - 2026)

Boston Scientific's Short term Debt history spans 18 years, with the latest figure at $41.0 million for Q1 2026.

  • On a quarterly basis, Short term Debt fell 94.72% to $41.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $41.0 million, a 94.72% decrease, with the full-year FY2025 number at $299.0 million, down 83.18% from a year prior.
  • Short term Debt hit $41.0 million in Q1 2026 for Boston Scientific, down from $299.0 million in the prior quarter.
  • Over the last five years, Short term Debt for BSX hit a ceiling of $1.8 billion in Q4 2024 and a floor of $20.0 million in Q3 2022.
  • Historically, Short term Debt has averaged $631.5 million across 5 years, with a median of $510.0 million in 2023.
  • Biggest five-year swings in Short term Debt: skyrocketed 2555.0% in 2023 and later plummeted 94.72% in 2026.
  • Tracing BSX's Short term Debt over 5 years: stood at $20.0 million in 2022, then skyrocketed by 2555.0% to $531.0 million in 2023, then soared by 234.84% to $1.8 billion in 2024, then tumbled by 83.18% to $299.0 million in 2025, then tumbled by 86.29% to $41.0 million in 2026.
  • Business Quant data shows Short term Debt for BSX at $41.0 million in Q1 2026, $299.0 million in Q4 2025, and $483.0 million in Q3 2025.